Kotyla P - Search Results

1

Jak Inhibitors for Treatment of Autoimmune Diseases: Lessons from Systemic Sclerosis and Systemic Lupus Erythematosus.

Kotyla P, Gumkowska-Sroka O, Wnuk B, Kotyla K. Kotyla P, et al. Among authors: kotyla k. Pharmaceuticals (Basel). 2022 Jul 28;15(8):936. doi: 10.3390/ph15080936. Pharmaceuticals (Basel). 2022. PMID: 36015084 Free PMC article. Review.

2

A Controlled Trial of the Efficacy of a Training Walking Program in Patients Recovering from Abdominal Aortic Aneurysm Surgery.

Wnuk BR, Durmała J, Ziaja K, Kotyla P, Woźniewski M, Błaszczak E. Wnuk BR, et al. Among authors: kotyla p. Adv Clin Exp Med. 2016 Nov-Dec;25(6):1241-1371. doi: 10.17219/acem/62239. Adv Clin Exp Med. 2016. PMID: 28028979 Free article. Clinical Trial.

3

Cytometric Characterization of Main Immunocompetent Cells in Patients with Systemic Sclerosis: Relationship with Disease Activity and Type of Immunosuppressive Treatment.

Gumkowska-Sroka O, Jagoda K, Owczarek A, Helbig G, Giemza-Stokłosa J, Kotyla PJ. Gumkowska-Sroka O, et al. J Clin Med. 2019 May 8;8(5):625. doi: 10.3390/jcm8050625. J Clin Med. 2019. PMID: 31071980 Free PMC article.

4

Thromboembolic Adverse Drug Reactions in Janus Kinase (JAK) Inhibitors: Does the Inhibitor Specificity Play a Role?

Kotyla PJ, Engelmann M, Giemza-Stokłosa J, Wnuk B, Islam MA. Kotyla PJ, et al. Int J Mol Sci. 2021 Feb 28;22(5):2449. doi: 10.3390/ijms22052449. Int J Mol Sci. 2021. PMID: 33671049 Free PMC article. Review.

5

Differential Impact of Biologic Therapy on Heart Function Biomarkers in Rheumatoid Arthritis Patients: Observational Study on Etanercept, Adalimumab, and Tocilizumab.

Dubiel-Braszczok B, Nowak K, Owczarek A, Engelmann M, Gumkowska-Sroka O, Kotyla PJ. Dubiel-Braszczok B, et al. Curr Pharm Des. 2022;28(24):2029-2037. doi: 10.2174/1381612828666220527141532. Curr Pharm Des. 2022. PMID: 35638285

6

Adhesion molecules: a way to understand lupus.

Nowak K, Gumkowska-Sroka O, Kotyla P. Nowak K, et al. Among authors: kotyla p. Reumatologia. 2022;60(2):133-141. doi: 10.5114/reum.2022.115664. Epub 2022 May 18. Reumatologia. 2022. PMID: 35782027 Free PMC article. Review.

7

Immunopathogenesis and Novel Therapeutics Strategies of Systemic Lupus Erythematosus.

Kotyla P, Olesińska M. Kotyla P, et al. Int J Mol Sci. 2023 May 30;24(11):9470. doi: 10.3390/ijms24119470. Int J Mol Sci. 2023. PMID: 37298420 Free PMC article.

8

Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis.

Gumkowska-Sroka O, Kotyla K, Mojs E, Palka K, Kotyla P. Gumkowska-Sroka O, et al. Among authors: kotyla p. Pharmaceuticals (Basel). 2023 Jul 27;16(8):1066. doi: 10.3390/ph16081066. Pharmaceuticals (Basel). 2023. PMID: 37630981 Free PMC article. Review.

9

Immunogenetics of Systemic Sclerosis.

Gumkowska-Sroka O, Kotyla K, Kotyla P. Gumkowska-Sroka O, et al. Among authors: kotyla p. Genes (Basel). 2024 May 5;15(5):586. doi: 10.3390/genes15050586. Genes (Basel). 2024. PMID: 38790215 Free PMC article. Review.

10

[Heart involvement in systemic sclerosis].

Kruszec A, Kotyla P. Kruszec A, et al. Among authors: kotyla p. Pol Merkur Lekarski. 2016 Sep 29;41(243):156-159. Pol Merkur Lekarski. 2016. PMID: 27755519 Review. Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

72 results

Search Page